Once the prospective buyer has been in contact with an insurer of the IFA, personal sale how many will refer the person to a competitor? Probably none.
According to health insurance, which circulates among specialized counsellors, the practice of insurance companies offering commissions to the General IFA is booming.
It says: "The insurers that offer referral arrangements, which include health care AXA PPP, Bupa, PruHealth and WPA-claim that they can help the growth of the private health market."
The companies also defend the practice on the grounds that no information should be passed to the insurance without the consent of the client.
Among the insurers who do not pay for referrals IFAs are Aviva and Exeter friendly family. According to them, buyers should first seek "the advice of an independent expert, Advisor before investing in a health policy".
A specialist Advisor application "how brokers gives truly independent advice from anyway?" Martin Howell, CEO of MediSearch broker, asked: "How does know a consumer if the broker to whom they speak has 50 Financial Ombudsman Service complaints against their name, or that it only discusses the insurers who pay the highest Council?"
Specialist advisers are, in all cases, get a non-negligible commission of any insurance company that they sell to the individual. It can be as much as 45 percent of premium the first year, passing to 10 or 5 per cent on renewal. (The big difference between "original" and "renewal" is itself questionable. Who encourages the churning, in which the Adviser moves forever the client between suppliers. An antidote is to ask the Advisor how commission is on).
The squabble between different branches of the insurance industry may seem obscure, but if it helps consumers to be evasive on the purchase, it should be welcome.
Public health nurses ‧some took a beating in recent weeks. Compassionless and poorly trained, their standards at Mid Staffordshire NHS Trust dipped so low that hundreds of patients have suffered unnecessarily, leading to hundreds of avoidable deaths.
The Francis report, on the eve of Easter, to inject a benevolent spirit long in the profession; bar managers failed, jump on a similar position in another hospital; legal obligation to report malpractice; a prohibition of gagging clauses; publication of survival rates for treatments - such that it is made for heart surgery NHS.
Looking at this list, it is surprising how many are also needed in the private sector. There is no doubt that the standards of nursing care are higher in independent hospitals, and they basically avoided the MSRA plague in the 1990s. But anecdotal evidence suggest separate room for improvement in some units.
And, of course, the private sector dragging the NHS when it comes to the publication of data from hospitals including performance and those who work in them. State medicine is more open than the consumerist private sector. Something wrong here.
‧BUPA has been under the cosh. Customer in Britain for its health coverage numbers and welfare services, such as health, fell 6 percent in total UK to 2.7 million last year.
Profits fell, collapse of 22 per cent compared to 2011. The market leader has blamed the "disappointing" results on a weak economy, rising costs of health and the pressure of public expenditure.
But its competitors have done better. AXA PPP, second place in the market, has increased its workforce by policyholder by 3% last year. Third place Aviva UK Health shot to almost 9% more.
But overall, it's a different story. BUPA, which operates on a living non-dividend basis, amassed last year 11.8 million customers worldwide, an increase of 9% in 2011. Also, profits, have about 8%. Factors here were undertaken to success in Australia and expat insurance company Bupa International arm.
When it sold its British chain of some 30 hospitals private in 2007, Bupa announced plans to expand abroad. That the ILO's plan, at least, appears to be on the right track. And as the British health insurance market is in rapid decline and eurozone languishes, long term strategy of Bupa's going global seems wise.
No comments:
Post a Comment